中文 | English
Return
Total: 2031 , 1/204
Show Home Prev Next End page: GO
Author:(Xu JUAN)

1.The value of MSCTA in diagnosis of superior mesenteric artery lesions

Juan XU

Journal of Practical Radiology 2016;32(4):599-602

2.Diagnostic significance of immunophenotyping in the patients of myelodysplastic syndrome

Juan XU

Chinese Journal of Practical Internal Medicine 2001;0(05):-

3.Effects of alpha-lipoic acid on serum soluble intercellular adhesion molecule-1 and high sensitive-C reactive protein in patients with early diabetic nephropathy

Yun GAO ; Juan XU

Clinical Medicine of China 2012;28(1):32-34

4.Demographic Structure, Environmental Quality and Resident Expenditureson Health

Xiaoqing YE ; Juan XU

Chinese Health Economics 2014;(1):48-50

5.The Effect of Valsartan on the Plasma Endothelin of Patients With Chronic Renal Failure Complicating Hypertension Patients and Its Clinical Significance

Juan DU ; Xueming XU

China Pharmacy 2001;0(11):-

6.The reliability study of urinary microalbumin test by dry hemical method

Huabin XU ; Juan YANG

International Journal of Laboratory Medicine 2009;30(3):229-231

7.Correlation between plasma visfatin levels and type 2 diabetes mellitus with carotid atherosclerosis

Zhaoliang LI ; Juan XU

Journal of Chinese Physician 2011;13(2):194-196

8.The applying of immobilization with plaster cast in children's rehabilitation treatment after knee arthroscopic surgery

Juan CHEN ; Caiying XU

Chinese Journal of Practical Nursing 2015;31(17):1291-1294

9.Participation of Clinical Pharmacists in One Case of Severe Thrombocytopenia after Operation Treated with CRRT Anticoagulation

Zhao JUAN ; Xu HANG

China Pharmacist 2015;18(12):2110-2111

10.Effects of self-management strategies on the self-efficacy and self-management behavior in female college students with primary dysmenorrhea

Juan TANG ; Huilan XU

Chinese Journal of Behavioral Medicine and Brain Science 2016;25(4):367-371

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2031 , 1/204 Show Home Prev Next End page: GO